Menu

CME Corner

  Improving Early Recognition of Interstitial Lung Disease and the Management of Idiopathic Pulmonary Fibrosis


An early and accurate diagnosis of ILD and its specific type is vital to directing therapy and monitoring disease course and therapeutic response, but these conditions are commonly mischaracterized, and a correct diagnosis is often delayed. Additionally, treatment of ILD can be a challenge for clinicians; poor outcomes and health-related quality of life attest to the significant care gaps and treatment limitations that remain. Advances in the treatment of ILD, and particularly in idiopathic pulmonary fibrosis (IPF), hold promise for improved care and patient outcomes. These activities will examine strategies for identifying and accurately diagnosing ILD, as well as considerations for tailored management.

Target audience:

Pulmonologists, radiologists, pathologists, primary care and other health care providers who encounter patients with ILD.

ACTIVITIES
newsletter Identifying and Diagnosing Interstitial Lung Disease
Mobile + Online on Univadis
Start
newsletter

Idiopathic Pulmonary Fibrosis: Developing Evidence-Based Management Plans
Mobile + Online on Univadis

Start


Faculty

Mary E. Strek, MD
Professor of Medicine
Director, University of Chicago
Interstitial Lung Disease Program
Chair, Pulmonary Fibrosis Foundation
Clinical Care Network Registry Ancillary Studies Committee
Chicago, IL

Kevin R. Flaherty, MD, MS
Professor of Medicine
Director, University of Michigan
Interstitial Lung Disease Program
Chair, Pulmonary Fibrosis Foundation Clinical Care Network/Registry Steering Committee
Ann Arbor, MI

 

 

 

 

 

 

Main Menu
EDITOR'S PICKS